ArticleScientific reports2025
AI verification for spirulina's antimicrobial power in total coliform and Staphylococcus aureus isolated from tilapia fillet.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Seafood products, including fresh tilapia fillets, are highly susceptible to rapid quality deterioration due to microbial contamination, posing a significant concern for food safety and public health. This study investigated, both experimentally and through artificial intelligence modeling, the antimicrobial activity of Spirulina platensis (SP) extracts against two common foodborne pathogens: total coliforms and Staphylococcus aureus (S. aureus). SP extracts were obtained using the freeze-thaw method at concentrations of 0.5%, 1%, and 5% (w/v), labeled as EA, EB, and EC, respectively. Microbial analysis was conducted on 25 fresh Nile tilapia fillets. Each fish was divided into four quarters: one served as the control, while the remaining three were treated with the different SP extract concentrations. Bacterial counts were recorded before treatment and at 1, 24, and 48 h post-treatment, with samples stored at 4 °C throughout. The antimicrobial activity of the SP extracts was modeled using Artificial Neural Network (ANN) and Adaptive Neuro-Fuzzy Inference System (ANFIS) models. The results indicated that SP extracts effectively reduced total coliform and S. aureus counts in the treated fish fillets. Both ANN and ANFIS models accurately predicted the reduction in microbial counts, validating the experimental results. Among the treatments, EC (5% concentration) exhibited the highest antimicrobial activity, outperforming EB and EA. These findings suggest that SP extracts hold promise as a natural preservative for seafood and other food products, contributing to food safety and public health protection. Future research should focus on identifying and characterizing the bioactive compounds in SP extracts across different food matrices, with potential applications in the development of functional foods and novel therapeutics.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.